Axa’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-14,584
| Closed | -$1.24M | – | 78 |
|
|
2025
Q4 | $1.24M | Sell |
14,584
-2,508
| -15% | -$206K | 0.59% | 36 |
|
|
2025
Q3 | $1.33M | Sell |
17,092
-699,815
| -98% | -$54.7M | 0.67% | 35 |
|
|
2025
Q2 | $56.1M | Buy |
716,907
+71,796
| +11% | +$5.35M | 0.16% | 132 |
|
|
2025
Q1 | $46.8M | Sell |
645,111
-46,851
| -7% | -$3.35M | 0.15% | 136 |
|
|
2024
Q4 | $51.2M | Sell |
691,962
-83,539
| -11% | -$5.85M | 0.16% | 132 |
|
|
2024
Q3 | $51.2M | Sell |
775,501
-227,001
| -23% | -$16.5M | 0.15% | 141 |
|
|
2024
Q2 | $92.6M | Sell |
1,002,502
-373,433
| -27% | -$33.1M | 0.28% | 74 |
|
|
2024
Q1 | $131M | Buy |
1,375,935
+7,173
| +0.5% | +$603K | 0.39% | 54 |
|
|
2023
Q4 | $104M | Sell |
1,368,762
-100,130
| -7% | -$6.97M | 0.34% | 66 |
|
|
2023
Q3 | $102M | Sell |
1,468,892
-348,482
| -19% | -$28M | 0.36% | 65 |
|
|
2023
Q2 | $171M | Buy |
1,817,374
+447,265
| +33% | +$38.9M | 0.57% | 30 |
|
|
2023
Q1 | $113M | Sell |
1,370,109
-40,971
| -3% | -$3.22M | 0.39% | 58 |
|
|
2022
Q4 | $105M | Buy |
1,411,080
+223,287
| +19% | +$17.2M | 0.38% | 54 |
|
|
2022
Q3 | $98.1M | Sell |
1,187,793
-34,753
| -3% | -$3.34M | 0.39% | 56 |
|
|
2022
Q2 | $116M | Sell |
1,222,546
-72,835
| -6% | -$7.54M | 0.43% | 50 |
|
|
2022
Q1 | $152M | Sell |
1,295,381
-67,363
| -5% | -$7.56M | 0.43% | 40 |
|
|
2021
Q4 | $177M | Sell |
1,362,744
-303,351
| -18% | -$35.4M | 0.45% | 37 |
|
|
2021
Q3 | $189M | Buy |
1,666,095
+393,740
| +31% | +$44.9M | 0.53% | 28 |
|
|
2021
Q2 | $132M | Buy |
1,272,355
+53,019
| +4% | +$5M | 0.37% | 58 |
|
|
2021
Q1 | $102M | Sell |
1,219,336
-72,019
| -6% | -$6.09M | 0.31% | 73 |
|
|
2020
Q4 | $118M | Sell |
1,291,355
-112,123
| -8% | -$9.3M | 0.37% | 59 |
|
|
2020
Q3 | $112M | Sell |
1,403,478
-296,042
| -17% | -$23.1M | 0.4% | 50 |
|
|
2020
Q2 | $117M | Buy |
1,699,520
+263,336
| +18% | +$18.7M | 0.46% | 43 |
|
|
2020
Q1 | $90.3M | Sell |
1,436,184
-34,719
| -2% | -$2.5M | 0.45% | 49 |
|
|
2019
Q4 | $114M | Buy |
1,470,903
+56,259
| +4% | +$4.39M | 0.47% | 38 |
|
|
2019
Q3 | $104M | Buy |
1,414,644
+262,776
| +23% | +$18.5M | 0.41% | 49 |
|
|
2019
Q2 | $70.9M | Buy |
1,151,868
+149,007
| +15% | +$9.01M | 0.28% | 94 |
|
|
2019
Q1 | $64M | Buy |
1,002,861
+198,927
| +25% | +$11.4M | 0.25% | 112 |
|
|
2018
Q4 | $41M | Buy |
803,934
+52,866
| +7% | +$2.67M | 0.18% | 150 |
|
|
2018
Q3 | $43.6M | Buy |
751,068
+290,775
| +63% | +$14.2M | 0.16% | 171 |
|
|
2018
Q2 | $22.3M | Buy |
460,293
+47,190
| +11% | +$2.2M | 0.09% | 269 |
|
|
2018
Q1 | $19.2M | Sell |
413,103
-90,126
| -18% | -$3.91M | 0.08% | 298 |
|
|
2017
Q4 | $18.9M | Sell |
503,229
-1,977
| -0.4% | -$72.6K | 0.07% | 309 |
|
|
2017
Q3 | $18.4M | Sell |
505,206
-139,131
| -22% | -$5.31M | 0.08% | 290 |
|
|
2017
Q2 | $25.4M | Sell |
644,337
-49,725
| -7% | -$1.81M | 0.12% | 224 |
|
|
2017
Q1 | $21.8M | Sell |
694,062
-12,144
| -2% | -$380K | 0.1% | 253 |
|
|
2016
Q4 | $22.1M | Sell |
706,206
-590,970
| -46% | -$19.1M | 0.1% | 237 |
|
|
2016
Q3 | $52.1M | Sell |
1,297,176
-220,572
| -15% | -$8.31M | 0.23% | 132 |
|
|
2016
Q2 | $50.5M | Buy |
1,517,748
+787,464
| +108% | +$26.9M | 0.22% | 131 |
|
|
2016
Q1 | $21.5M | Buy |
730,284
+19,416
| +3% | +$536K | 0.1% | 251 |
|
|
2015
Q4 | $18.7M | Sell |
710,868
-35,316
| -5% | -$917K | 0.08% | 258 |
|
|
2015
Q3 | $17.7M | Sell |
746,184
-8,550
| -1% | -$206K | 0.07% | 265 |
|
|
2015
Q2 | $17.9M | Buy |
754,734
+125,892
| +20% | +$2.84M | 0.07% | 271 |
|
|
2015
Q1 | $14.9M | Buy |
628,842
+129,234
| +26% | +$2.9M | 0.06% | 314 |
|
|
2014
Q4 | $10.6M | Buy |
499,608
+1,680
| +0.3% | +$33.8K | 0.04% | 377 |
|
|
2014
Q3 | $8.48M | Buy |
497,928
+16,698
| +3% | +$264K | 0.04% | 410 |
|
|
2014
Q2 | $6.88M | Sell |
481,230
-8,466
| -2% | -$115K | 0.03% | 479 |
|
|
2014
Q1 | $6.05M | Buy |
489,696
+7,404
| +2% | +$85.4K | 0.03% | 486 |
|
|
2013
Q4 | $5.29M | Sell |
482,292
-44,208
| -8% | -$498K | 0.02% | 511 |
|
|
2013
Q3 | $6.11M | Buy |
526,500
+19,830
| +4% | +$232K | 0.03% | 481 |
|
|
2013
Q2 | $5.67M | Buy |
+506,670
| New | +$6M | 0.03% | 463 |
|
Other funds holding EW
VCM
VPM
Axa's EW Position: Q1 2026 in Review
Axa sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 14,584 shares — an estimated $1.24M sold.
Axa first reported a position in EW in Q2 2013 and held it in 51 quarters. The position peaked at $189M in Q3 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Axa reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
- Axa sold 14,584 Edwards Lifesciences shares in Q1 2026, an estimated $1.24M.
- Axa first reported a position in Edwards Lifesciences in Q2 2013 and held it in 51 quarters.
- Axa's Edwards Lifesciences position peaked at $189M in Q3 2021.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Axa's 13F filing for Q1 2026, filed 15 May 2026.